Revised SPC: Qtern (saxagliptin hydrochloride, dapagliflozin propanediol monohydrate) 5mg/10mg film-coated tablets
SPC now advises discontinuation of treatment if GFR falls persistently below 45mL/min and warns if a patient develops blisters and bullous pemphigoid is suspected, Qtern should be discontinued and patient referred to dermatologist.
Source:
electronic Medicines compendium